Meprednisone

A corticosteroid with a chemical structure and clinical effects similar to prednisone. It is a metabolite of methylprednisolone (Bago 2006).
It has a predominantly glucocorticoidal action with little mineralocorticoidal action.
Oral administration or injectable every 6 to 24 hours.
It has very few bibliographical references and its pharmacokinetics are little known (Gador 2011, Bago 2006).

Since the last update date we have not found published data on its excretion in breastmilk.

Its high percentage of plasmatic protein binding makes it unlikely it will transfer to milk in significant amounts.
Other corticosteroids with a similar structure and actions are excreted in milk in insignificant amounts and are considered compatible with breastfeeding.
Corticosteroids are commonly used in pediatrics and lack side effects when they are used alone or in short-term treatments.

Until there is more published data about this drug in relation to breastfeeding, safer alternatives may be preferred, especially during the neonatal period and in the case of prematurity.

Alternatives

• Methylprednisolone (Very Low Risk)
• Prednisone (Very Low Risk)
• Prednisolone (Very Low Risk)